Cargando…
Experimental study of the anti-atherosclerotic effect of demethylzeylasteral
This study aimed to confirm that atherosclerosis (AS) is a systemic immune-mediated chronic inflammatory disease and to investigate the anti-atherosclerotic effect of demethylzeylasteral by testing the immunocompetent cells and inflammatory mediators in the blood and atherosclerotic plaques of the r...
Autores principales: | Huang, Ying, Wang, Shaofeng, Zhang, Chunya, Xu, Zhiqing, Shen, Jinghua, Du, Xiaogang, Zhang, Huanhua, Zhang, Kangjian, Zhang, Daifu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450521/ https://www.ncbi.nlm.nih.gov/pubmed/28587342 http://dx.doi.org/10.3892/etm.2017.4352 |
Ejemplares similares
-
Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo
por: Chang, Yuqian, et al.
Publicado: (2023) -
Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells
por: Yang, Yang, et al.
Publicado: (2020) -
Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer
por: Chang, Jie, et al.
Publicado: (2022) -
Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms
por: Shen, Zhengjie, et al.
Publicado: (2022) -
Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis
por: Zhang, Kui, et al.
Publicado: (2018)